AGX814

SARS-Cov-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 616

suitable for ELISA

• Sinonimo/i: 2019-nCoV, COVID-19
• Codice UNSPSC: 51201600
• NACRES: NA.26

Proprietà

• Ricombinante: expressed in E. coli
• Livello qualitativo: 100
• Forma fisica: liquid
• PM: ≤72 kDa
• Condizioni di stoccaggio: avoid repeated freeze/thaw cycles
• tecniche: ELISA: suitable
• Condizioni di spedizione: dry ice

Descrizione

Descrizione generale

SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, expressed in E. coli, Cat. No. AGX814 is for use in ELISA.

Descrizione del bersaglio

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleoprotein antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

Stato fisico

Purified protein in 25mM Tris-HCl without preservatives, pH 8.0.

Ricostituzione

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Stoccaggio e stabilità

Stable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.

Esclusione di responsabilità

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Informazioni sulla sicurezza

• Codice della classe di stoccaggio: 12 - Non Combustible Liquids
• Classe di pericolosità dell'acqua (WGK): nwg
• Punto d’infiammabilità (°F): Not applicable
• Punto d’infiammabilità (°C): Not applicable